Höti N - Search Results

1

Armoring CRAds with p21/Waf-1 shRNAs: the next generation of oncolytic adenoviruses.

Höti N, Chowdhury WH, Mustafa S, Ribas J, Castanares M, Johnson T, Liu M, Lupold SE, Rodriguez R. Höti N, et al. Cancer Gene Ther. 2010 Aug;17(8):585-97. doi: 10.1038/cgt.2010.15. Epub 2010 May 7. Cancer Gene Ther. 2010. PMID: 20448671 Free PMC article.

2

Chronic administration of valproic acid inhibits prostate cancer cell growth in vitro and in vivo.

Xia Q, Sung J, Chowdhury W, Chen CL, Höti N, Shabbeer S, Carducci M, Rodriguez R. Xia Q, et al. Among authors: hoti n. Cancer Res. 2006 Jul 15;66(14):7237-44. doi: 10.1158/0008-5472.CAN-05-0487. Cancer Res. 2006. PMID: 16849572

3

Valproic acid, a histone deacetylase inhibitor, is an antagonist for oncolytic adenoviral gene therapy.

Höti N, Chowdhury W, Hsieh JT, Sachs MD, Lupold SE, Rodriguez R. Höti N, et al. Mol Ther. 2006 Dec;14(6):768-78. doi: 10.1016/j.ymthe.2006.07.009. Epub 2006 Sep 20. Mol Ther. 2006. PMID: 16990052 Free article.

4

Androgen receptor attenuation of Ad5 replication: implications for the development of conditionally replication competent adenoviruses.

Höti N, Li Y, Chen CL, Chowdhury WH, Johns DC, Xia Q, Kabul A, Hsieh JT, Berg M, Ketner G, Lupold SE, Rodriguez R. Höti N, et al. Mol Ther. 2007 Aug;15(8):1495-503. doi: 10.1038/sj.mt.6300223. Epub 2007 Jun 12. Mol Ther. 2007. PMID: 17565351 Free article.

5

Bicalutamide-activated oncolytic adenovirus for the adjuvant therapy of high-risk prostate cancer.

Johnson TJ, Höti N, Liu C, Chowdhury WH, Li Y, Zhang Y, Lupold SE, Deweese T, Rodriguez R. Johnson TJ, et al. Among authors: hoti n. Cancer Gene Ther. 2013 Jul;20(7):394-402. doi: 10.1038/cgt.2013.34. Epub 2013 Jun 14. Cancer Gene Ther. 2013. PMID: 23764901 Free PMC article.

6

Giant Benign Prostatic Hyperplasia in a Pakistani Patient.

Khan Z, Tahir M, Ashraf HS, Khan Niazi F, Khan M, Mustafa S, Höti N. Khan Z, et al. Among authors: hoti n. Urol Case Rep. 2014 Jan 24;2(1):33-4. doi: 10.1016/j.eucr.2013.11.006. eCollection 2014 Jan. Urol Case Rep. 2014. PMID: 26955540 Free PMC article.

7

Overexpression of Exportin-5 Overrides the Inhibitory Effect of miRNAs Regulation Control and Stabilize Proteins via Posttranslation Modifications in Prostate Cancer.

Höti N, Yang S, Aiyetan P, Kumar B, Hu Y, Clark D, Eroglu AU, Shah P, Johnson T, Chowdery WH, Zhang H, Rodriguez R. Höti N, et al. Neoplasia. 2017 Oct;19(10):817-829. doi: 10.1016/j.neo.2017.07.008. Epub 2017 Sep 4. Neoplasia. 2017. PMID: 28881308 Free PMC article.

8

Evaluating the Oncogenic and Tumor Suppressor Role of XPO5 in Different Tissue Tumor Types.

Khan M, Khan Z, Uddin Y, Mustafa S, Shaukat I, Pan J, Höti N. Khan M, et al. Among authors: hoti n. Asian Pac J Cancer Prev. 2018 Apr 27;19(4):1119-1125. doi: 10.22034/APJCP.2018.19.4.1119. Asian Pac J Cancer Prev. 2018. PMID: 29699373 Free PMC article.

9

Loss of Cyclin-Dependent Kinase Inhibitor Alters Oncolytic Adenovirus Replication and Promotes More Efficient Virus Production.

Höti N, Johnson TJ, Chowdhury WH, Rodriguez R. Höti N, et al. Cancers (Basel). 2018 Jun 15;10(6):202. doi: 10.3390/cancers10060202. Cancers (Basel). 2018. PMID: 29914081 Free PMC article.

10

Aggressive Metastatic GATA3-Positive Sarcomatoid Carcinoma with Rapid Progression and Invasion of the Liver.

Shaukat I, Padgett C, Inayat M, Höti N, Mustafa S. Shaukat I, et al. Among authors: hoti n. Case Rep Oncol Med. 2018 Sep 10;2018:6469591. doi: 10.1155/2018/6469591. eCollection 2018. Case Rep Oncol Med. 2018. PMID: 30310702 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters